News Morinaga Milk Industry Co., Ltd.

Equities

2264

JP3926800008

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-23 am EDT			5-day change	1st Jan Change
3,056 ^JPY	-0.10%		+1.99%	+12.02%

Feb. 09	Morinaga Milk Industry Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024	CI
Jan. 18	Morinaga Milk Industry Relocates Headquarters to a Newer Building in Minato-ku, Tokyo	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ex-dividend day for final dividend	Mar. 27	FA
Morinaga Milk Industry Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024	Feb. 09	CI
Morinaga Milk Industry Relocates Headquarters to a Newer Building in Minato-ku, Tokyo	Jan. 18	MT
Morinaga Milk Industry Co., Ltd. Announces Change of Address	Jan. 18	CI
Split: 2 of 1	Nov. 28	FA
Morinaga Milk’s Probiotic Bifidobacterium breve B-3 Receives Approval of Individual Recognized Registration in South Korea	Nov. 16	BU
Morinaga Milk Industry Co., Ltd.'s Probiotic Bifidobacterium B-3 Receives Approval of Individual Recognized Registration in South Korea	Nov. 16	CI
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	Nov. 01	CI
Morinaga Milk Industry Co., Ltd.'s Equity Buyback announced on May 15, 2023, has closed with 1,856,400 shares, representing 4.14% for ¥9,999.53 million.	23-10-30	CI
Morinaga Milk Industry Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	23-10-26	CI
Morinaga Milk Industry Co., Ltd. Revises Earnings Guidance for the First Six Months Ended September 30, 2023 and for the Fiscal Year Ending March 31, 2024	23-10-26	CI
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	23-10-02	CI
Morinaga Milk's Probiotic Bifidobacterium longum subsp. longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil	23-09-07	BU
Morinaga Milk Industry Co., Ltd.'s Probiotic Bifidobacterium Longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil	23-09-07	CI
Morinaga Milk Industry Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2024	23-08-09	CI
Morinaga Milk Industry Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	23-08-09	CI
Morinaga Milk Industry Issues Restricted Stock Compensation	23-08-02	MT
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	23-07-03	CI
Morinaga Milk Industry Co., Ltd. completed the acquisition of 20% stake in Morinaga Le May Vietnam Joint Stock Company from Le Van May and Do Thanh Tuan.	23-05-30	CI
Morinaga Milk Industry Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Morinaga Milk Industry Co., Ltd.

Equities

2264

JP3926800008

Summary

Filters